GlassScriptPhysician profile
Aftab H Patni
NPI 1043214307
$5,046.87
in general payments reported to CMS, 2019-2025
6 companies · $1,229 in 2025
The $1,229 reported for 2025 was more than what 83% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110 · 2021: $23.93 · 2022: $269 · 2023: $70.91 · 2024: $3,343 · 2025: $1,229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,056 · Food and Beverage: $588.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,055.81 |
| Food and Beverage | $587.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oticon Medical, LLC | $3,343.17 | 2024 | Ponto Bone Anchored Hearing System |
| Med-El Corporation | $1,229.86 | 2019-2025 | Mi1250 Synchrony 2 Flexsoft, Bci 602 Kit, Adhear Professional Kit |
| Cochlear Americas | $339.97 | 2022-2023 | Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha |
| Integra Lifesciences Corporation | $65.88 | 2025 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Advanced Bionics, LLC | $44.06 | 2019 | |
| Acclarent, INC | $23.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aftab Patni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.